I think this is a most exciting research which would improve the wellness of many people with vision disability , wish you all the success and keep up with the good work
"While the epiretinal electrode array is expected to have lower thresholds than the suprachoroidal electrode array our preclinical studies have shown that the levels required to evoke visual activity remain well within maximum safe limits. The advantages associated with this approach include relatively simple and safe surgical approach without the need to have the electrode array or leadwires within the vitreous." - Rob
"Clinical trials will be performed initially using the suprachoroidal electrode array commencing early 2013. Following completion of the preclinical studies for the high density epiretinal array this device will also undergo clinical trials". - Rob
Nice work! Will the clinical trials be performed with epiretinal Phase 2 implant or suprachoroidal Phase 1 as well? I don't quite understand why research was started with suprachoroidal implant that required switching the technology due to the implant rigidness. Also, suprachoroidal implant seems to require higher stimulation currents as compared to the epiretinal, which is a disadvantage. What are its advantages?
